# Systolic Blood Pressure Intervention Trial

> **NCT01206062** · NA · COMPLETED · sponsor: **National Heart, Lung, and Blood Institute (NHLBI)** · enrollment: 9361 (actual)

## Conditions studied

- Hypertension

## Interventions

- **DRUG:** Intensive control of SBP
- **DRUG:** Standard control of SBP

## Key facts

- **NCT ID:** NCT01206062
- **Lead sponsor:** National Heart, Lung, and Blood Institute (NHLBI)
- **Sponsor class:** NIH
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2010-10
- **Primary completion:** 2016-07
- **Final completion:** 2019-03
- **Target enrollment:** 9361 (ACTUAL)
- **Last updated:** 2021-01-08

## Collaborators

- [object Object]
- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT01206062

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT01206062, "Systolic Blood Pressure Intervention Trial". Retrieved via AI Analytics 2026-07-02 from https://api.ai-analytics.org/clinical/NCT01206062. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*